Hydrolytic Metabolism of Cyanopyrrolidine DPP-4 Inhibitors Mediated by Dipeptidyl Peptidases

Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics

Linn Fagerberg, Björn M. Hallström, Per Oksvold et al. · Molecular & Cellular Proteomics · 2013 · 3.8K citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Discovery and Preclinical Profile of Saxagliptin (BMS-477118):  A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 621 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Molecular characterization of dipeptidyl peptidase activity in serum

Christine Durinx, Anne‐Marie Lambeir, Eugène Bosmans et al. · European Journal of Biochemistry · 2000 · 272 citations · Full text

Life Sciences, Biochemistry, Immunology +8

Structural Basis of Proline-Specific Exopeptidase Activity as Observed in Human Dipeptidyl Peptidase-IV

Ralf Thoma, Bernd Löffler, M. Stihle et al. · Structure · 2003 · 240 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans

Handan He, Phi Tran, Hequn Yin et al. · Drug Metabolism and Disposition · 2008 · 139 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +8